Moderna, Inc. (MRNA) › Operating IncomeModerna, Inc. (MRNA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$223.77M2017: -$269.36M2018: -$413.27M2019: -$546.00M2020: -$763.00M2021: $13.30B2022: $9.42B2023: -$4.24B2024: -$3.94B2025: -$3.07B-$3.07B2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.07B+22.1%2024-$3.94B+6.9%2023-$4.24B-145.0%2022$9.42B-29.2%2021$13.30B+1842.6%2020-$763.00M-39.7%2019-$546.00M-32.1%2018-$413.27M-53.4%2017-$269.36M-20.4%2016-$223.77M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share